PERIPHERAL EDEMA DUE TO INCREASED VASCULAR-PERMEABILITY - A CLINICAL APPRAISAL

被引:11
作者
AGOSTONI, A
CICARDI, M
PORRECA, W
机构
[1] Institute of Internal Medicine, University of Milan, Milan, I-20122
关键词
ANGIOEDEMA; INCREASED VASCULAR PERMEABILITY; VASOACTIVE MEDIATORS;
D O I
10.1007/BF02591654
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The release of vasoactive substances produces reversible changes of endothelial permeability with consequent edematous syndromes. We present 899 patients referred to our clinic for "non-hydrostatic non-hyponcotic" recurrent edema problems. Personal and family histories were recorded and a complete physical examination was carried out for each patient. In chronic situations laboratory tests [blood cell count, cryoglobulins, thyroid hormones, complement components (C3, C4, C1 inhibitor), total IgE, skin testing] were performed. Four subgroups of angioedema are identified for relevant clinical and etiopathogenetic differences. Seventy-three percent of patients had an urticaria-angioedema syndrome responding to antihistamine and/or corticosteroid treatment (histamine-dependent angioedema). Twenty-three percent had an angioedema related to a deficiency in C1 esterase inhibitor (complement-dependent angioedema). In a minority of patients, angioedema was due to the pharmacological effect of a drug (pharmacological angioedema) or was of a totally unknown origin (idiopathic angioedema). A generalized increase in vascular permeability was reported in 3 patients (systemic capillary leak syndrome). A brief survey of the literature is given with the review of our patients.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 49 条
  • [1] AGOSTONI A, 1991, AM J MED, V90, P278
  • [2] AGOSTONI A, 1988, COMPLEMENT INFLAMM, V6, P112
  • [3] AUTOANTIBODY-MEDIATED ACQUIRED DEFICIENCY OF C1 INHIBITOR
    ALSENZ, J
    BORK, K
    LOOS, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (22) : 1360 - 1366
  • [4] STUDIES OF THE MECHANISM OF ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR-ASSOCIATED ANGIOEDEMA - THE EFFECT OF AN ACE INHIBITOR ON CUTANEOUS RESPONSES TO BRADYKININ, CODEINE, AND HISTAMINE
    ANDERSON, MW
    DESHAZO, RD
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (05) : 856 - 858
  • [5] TYPE-I C1 INHIBITOR DEFICIENCY WITH A SMALL MESSENGER-RNA RESULTING FROM DELETION OF ONE EXON
    ARIGA, T
    IGARASHI, T
    RAMESH, N
    PARAD, R
    CICARDI, M
    DAVIS, AE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) : 1888 - 1893
  • [6] IDENTIFICATION OF A NEW P1 RESIDUE MUTATION (444ARG-]SER) IN A DYSFUNCTIONAL C1 INHIBITOR PROTEIN CONTAINED IN A TYPE-II HEREDITARY ANGIOEDEMA PLASMA
    AULAK, KS
    CICARDI, M
    HARRISON, RA
    [J]. FEBS LETTERS, 1990, 266 (1-2): : 13 - 16
  • [7] HUMAN C1BAR INHIBITOR - PRIMARY STRUCTURE, CDNA CLONING, AND CHROMOSOMAL LOCALIZATION
    BOCK, SC
    SKRIVER, K
    NIELSEN, E
    THOGERSEN, HC
    WIMAN, B
    DONALDSON, VH
    EDDY, RL
    MARRINAN, J
    RADZIEJEWSKA, E
    HUBER, R
    SHOWS, TB
    MAGNUSSON, S
    [J]. BIOCHEMISTRY, 1986, 25 (15) : 4292 - 4301
  • [8] THERAPY OF CHRONIC IDIOPATHIC URTICARIA WITH NIFEDIPINE - DEMONSTRATION OF BENEFICIAL EFFECT IN A DOUBLE-BLINDED, PLACEBO-CONTROLLED, CROSSOVER TRIAL
    BRESSLER, RB
    SOWELL, K
    HUSTON, DP
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (04) : 756 - 763
  • [9] CASPRITZ G, 1986, IRCS MED SCI-BIOCHEM, V14, P568
  • [10] RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF THE C1 INHIBITOR GENE IN HEREDITARY ANGIONEUROTIC-EDEMA
    CICARDI, M
    IGARASHI, T
    KIM, MS
    FRANQI, D
    AGOSTONI, A
    DAVIS, AE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) : 1640 - 1643